Table 2.
Anthropometric, biochemical, and hormonal characteristics of patients with obesity and type 2 diabetes mellitus undergoing bariatric surgery
Controls | V1 | V2 | V3 | V4 | |
---|---|---|---|---|---|
Number | 22 | 13 | 13 | 13 | 13 |
Age (year) | 51.6 ± 1.33 | 56.2 ± 2.13 | NP | NP | NP |
Body mass index (kg/m2) | 23.4 ± 0.44 | 41.6 ± 1.69* | 37.0 ± 1.63* | 34.4 ± 1.79*,** | 35.4 ± 1.79*,** |
Blood glucose (mmol/l) | 4.91 ± 0.08 | 10.2 ± 1.19* | 6.47 ± 0.53*,** | 6.69 ± 0.54*,** | 8.12 ± 1.11* |
HbA1c (mmol/mol) | 37.5 ± 0.81 | 66.3 ± 4.84* | 54.6 ± 3.15*,** | 53.4 ± 4.67*,** | 53.9 ± 4.62*,** |
Total cholesterol (mmol/l) | 5.18 ± 0.22 | 5.35 ± 0.29 | 4.69 ± 0.35 | 4.96 ± 0.33 | 4.56 ± 0.16 |
Triglycerides (mmol/l) | 1.12 ± 0.12 | 2.86 ± 0.73* | 1.76 ± 0.24*,** | 1.85 ± 0.28** | 1.71 ± 0.26** |
HDL cholesterol (mmol/l) | 1.65 ± 0.07 | 1.21 ± 0.07* | 1.09 ± 0.06* | 1.26 ± 0.07*,*** | 1.29 ± 0.07*,*** |
LDL cholesterol (mmol/l) | 3.03 ± 0.17 | 3.19 ± 0.33 | 2.81 ± 0.29 | 2.86 ± 0.26 | 2.50 ± 0.17 |
Insulin (mUI/l) | 16.6 ± 0.76 | 97.1 ± 33.01* | 65.7 ± 28.0* | 72.5 ± 32.6*,** | 64.0 ± 24.6* |
Leptin (ng/ml) | 13.3 ± 2.00 | 39.2 ± 5.82* | 20.6 ± 4.10** | 21.3 ± 5.18** | 24.0 ± 5.71** |
hsC-reactive protein (mg/l) | 0.20 ± 0.05 | 3.88 ± 0.83* | 2.04 ± 0.51* | 2.50 ± 0.88* | 1.61 ± 0.42*,** |
HOMA index | 3.64 ± 0.20 | 46.36 ± 19.67* | 19.95 ± 8.93*,** | 27.33 ± 14.26*,** | 22.73 ± 9.36* |
ANGPTL4 mRNA expression in SAT | 1.04 ± 0.09 | 1.15 ± 0.17 | 1.25 ± 0.19 | 0.94 ± 0.15 | 1.10 ± 0.11 |
Values are mean ± SEM
NP non-measured parameter, V1 before bariatric surgery, V2 1 month after bariatric surgery, V3 3 months after bariatric surgery, V4 1 year after bariatric surgery
*p < 0.05 vs. controls, one-way ANOVA/ANOVA on ranks; **p < 0.05 vs. V1, one-way repeated measures ANOVA/one-way repeated measures ANOVA on ranks; ***p < 0.05 vs. V2, one-way repeated measures ANOVA/one-way repeated measures ANOVA on ranks